Company
SOLV +2.60%Solventum Corporation
Market Cap: $14.80 Billion
USD as of Aug 2, 2026
$SOLV +2.60% $SOLV United States Healthcare Health Information Services US Healthcare US Health Information ServicesSolventum Corporation Market Capitalization Over Time
View HistoryEvolution of Solventum Corporation market cap in the past 5 years
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: Health Information Services
| Company | Market Cap (USD) |
|---|---|
| Veeva Systems | $33.10 B |
| GE HealthCare | $30.72 B |
| Pro Medicus Limited | $11.92 B |
| BrightSpring Health Services, Inc. | $11.72 B |
| M3, Inc. | $11.08 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
| Lilly | $1.024 T |
| Johnson & Johnson | $617.78 B |
| AbbVie | $443.36 B |
| Roche | $418.93 B |
| UnitedHealth Group | $376.34 B |
Detailed Description
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Financials
| Last Financial Reports Date | March 31, 2026 |
| Revenue TTM | $8.26 B |
| EBITDA | $1.02 B |
| Gross Profit TTM | $4.43 B |
| Profit Margin | 17.33% |
| Operating Margin | 5.58% |
| Quarterly Revenue Growth | -3.00% |
Stocks & Indexes
Solventum Corporation main stocks and indexes inclusions.
$SOLVRussell 1000 Russell 3000 S&P 500